Compare Oscar Health Inc (OSCR) vs Vale SA (VALE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Oscar Health Inc vs Vale SA — how do they compare? Oscar Health Inc trades at $28.79 (market cap $9.28B), while Vale SA trades at $14.87 (market cap $60.30B). The key difference: Vale SA is far larger — about 6.5× Oscar Health Inc's market cap, and Vale SA pays a 8.83% dividend while Oscar Health Inc pays none. Which is the better fit depends on your goals.
| OSCR | VALE | |
|---|---|---|
Market Cap | $9.28B | $60.30B |
Sector | Health | Basic Materials |
52-Week High | $32.18 | $17.82 |
52-Week Low | $10.85 | $9.53 |
Enterprise Value | $4.90B | $77.22B |
Dividend Yield | — | 8.83% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Oscar Health (OSCR) trades at $29.60, up 1.72% with mixed technical signals showing neutral overall momentum. The company reported strong Q1 2026 earnings beat but faces profitability challenges with negative margins. Revenue growth from $11.7B in 2025 to projected $13.3B in 2026 indicates expansion, while cash flow trends show operational improvement. Analyst consensus is divided with 27% buy ratings against a $24.67 price target below current levels.
The stock presents growth potential through revenue expansion and cash flow generation, but profitability concerns and negative ROE pose significant risks. Current valuation at 0.61 P/S suggests reasonable pricing for growth, though execution on margin improvement remains critical for sustained upside.
VALE trades at $14.85, up 5.32% today, showing recent volatility amid mixed earnings results. The stock faces bearish technical signals with moving averages indicating downward pressure, while fundamentals reveal declining profitability with net margins dropping from 42.85% in 2022 to 6.12% in 2025. Recent news highlights governance challenges and a $2.56 billion decarbonization investment plan announced in June 2026. Cash flow remains positive at $2.42 billion for 2025, supporting ongoing operations despite earnings volatility.
Analyst consensus leans cautious with 40.54% buy ratings and a $17.13 price target offering 15% upside potential. Key risks include earnings inconsistency, commodity price exposure, and governance issues. The valuation appears reasonable with P/E of 21.59 and EV/EBITDA of 7.25, but investors should weigh declining margins against the company's strategic investments in sustainability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Oscar Health Inc
Oscar Health, Inc. is a health insurance company that utilizes a technology-driven approach to simplify the healthcare experience. The company offers individual, small-group, and Medicare Advantage plans, primarily through a platform that integrates technology, data, and design to provide members with a personalized, efficient healthcare journey. Oscar aims to lower costs and improve engagement by focusing on consumer-centricity and modernizing the traditional health insurance model.
Read more on OSCR →About Vale SA
Vale is the world's largest iron ore miner and one of the largest diversified miners, along with BHP and Rio Tinto. Earnings are dominated by the bulk materials division, primarily iron ore and iron ore pellets, with minor contributions from iron ore proxies, including manganese and coal. The base metals division is much smaller, primarily consisting of nickel mines and smelters with a small contribution from copper.
Read more on VALE →
